While further studies are required to decipher the role of IRF1 in leukemia and the relationship between IRF1 expression and clinical features, such as overall survival and therapy response, our results suggest the potential of IRF1-based patient stratification for identification of AML subgroups with distinct disease features. This evidence concerns the gene IRF1 and leukemia.